Patents by Inventor Dylan Jacobs

Dylan Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970731
    Abstract: The invention relates to compounds, methods and compositions for improving on nucleic acid polymerization, including DNA replication by in vitro primer extension to generate, for example, polymers for nanopore-based single molecule sequencing of a DNA template. A nucleic acid polymerase reaction composition is provided with polymerization enhancement moieties, which allows enhanced DNA polymerase activity with nucleotide analogs, resulting in improved length of primer extension products for sequencing applications.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: April 30, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Mark Stamatios Kokoris, John Tabone, Melud Nabavi, Aaron Jacobs, Dylan O'Connell, Drew Goodman, Lacey Merrill, Jagadeeswaran Chandrasekar, Kendall Berg, Samantha Vellucci, Jessica Vellucci
  • Publication number: 20240057582
    Abstract: A bait station for pest control, the bait station comprising: an enclosure defining an access chamber and a bait chamber, said access chamber including at least one entry port for permitting entry of a pest into said enclosure, said bait chamber configured to hold therein bait material harmful to the pest; and a load sensing module arranged in the bait chamber for sensing changes in weight of bait material positioned in said bait chamber and operable to output signal indicative of sensed changes in weight of the bait material and transmit said output signal to a remote location.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 22, 2024
    Applicant: PestSense Holdings Pty Limited
    Inventor: Dylan Jacob Gannan
  • Patent number: 10579141
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: March 3, 2020
    Assignee: North Inc.
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018483
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018485
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018481
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018484
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018482
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Publication number: 20190018480
    Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Idris S. Aleem, Mayank Bhargava, Dylan Jacobs
  • Patent number: 8575208
    Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: November 5, 2013
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Luc Farmer, Randy Scott Bethiel, Dylan Jacobs, Robert B. Perni, John Maxwell, Kevin Cottrell, Summer Halas
  • Patent number: 8481524
    Abstract: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: July 9, 2013
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: David Lauffer, Pan Li, Nathan Waal, Kira Mcginty, Qing Tang, Steven Ronkin, Luc Farmer, Dean Shannon, Dylan Jacobs
  • Patent number: 8232406
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
    Type: Grant
    Filed: November 9, 2010
    Date of Patent: July 31, 2012
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: David J. Lauffer, Robert J. Davies, Dean Stamos, Alexander Aronov, David D. Deininger, Ronald Grey, Jr., Jinwang Xu, Pan Li, Brian Ledford, Luc Farmer, Randy Scott Bethiel, Dylan Jacobs, Kira McGinty
  • Publication number: 20110136789
    Abstract: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
    Type: Application
    Filed: March 31, 2010
    Publication date: June 9, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: David Lauffer, Pan Li, Nathan Waal, Kira Mcginty, Qing Tang, Steven Ronkin, Luc Farmer, Dean Shannon, Dylan Jacobs
  • Patent number: 7936891
    Abstract: A line array loudspeaker, including a first plurality of acoustic drivers each acoustic driver comprising an axis, the first plurality of acoustic drivers arranged so that the axes of first plurality of acoustic drivers are coplanar in a first plane and so that a straight line intersects each axis at a same position on each of the first plurality of acoustic drivers, and a second plurality of acoustic drivers each acoustic driver comprising an axis, the second plurality of acoustic drivers arranged so that the axes of second plurality of acoustic drivers are coplanar in a second plane and so that the straight line intersects each axis at a same position on each of the second plurality of acoustic drivers, in which the first plurality and the second plurality arranged so that the first plane intersects with the second plane along a straight intersection line.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: May 3, 2011
    Inventors: Clifford A. Henricksen, Christopher B. Ickler, Kenneth Dylan Jacob, Morten Jorgensen, Joseph J. Kutil, III, Hilmar Lehnert, Peter C. Santoro
  • Publication number: 20110059936
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
    Type: Application
    Filed: November 9, 2010
    Publication date: March 10, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: David J. Lauffer, Robert J. Davies, Dean Stamos, Alexander Aronov, David D. Deininger, Ronald Grey, JR., Jinwang Xu, Pan Li, Brian Ledford, Luc Farmer, Randy Scott Bethiel, Dylan Jacobs, Kira McGinty
  • Patent number: 7872031
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: January 18, 2011
    Assignee: Vertex Pharmaceuticals incorporated
    Inventors: David J. Lauffer, Robert J. Davies, Dean Stamos, Alexander Aronov, David D. Deininger, Ronald Grey, Jr., Jinwang Xu, Pan Li, Brian Ledford, Luc Farmer, Randy Scott Bethiel, Dylan Jacobs, Kira McGinty
  • Publication number: 20100272681
    Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
    Type: Application
    Filed: February 20, 2008
    Publication date: October 28, 2010
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Luc Farmer, Randy Scott Bethiel, Dylan Jacobs, Robert B. Perni, John Maxwell, Kevin Cottrell, Summer Halas
  • Publication number: 20100002889
    Abstract: The invention is directed to a display and method for conducting sound system design. The display is configured to simultaneously show a sound system model comprising both audio components and sound environment components, a plurality of parameters and a graphic representation of a calculated sound system performance attribute. In response to receiving input from the user and without any additional user intervention, the display re-displays a newly-calculated sound system performance attribute such as, for example, a graphic representation in the sound system model of a sound path associated with a user-selected reflected sound identifier. A processor also simulates, based on the sound system configuration, the sound performance that a user would expect to hear positioned in an identified listening position of the sound system model.
    Type: Application
    Filed: September 10, 2009
    Publication date: January 7, 2010
    Applicant: Bose Corporation
    Inventors: Morten Jorgensen, Michael C. Monks, Lisa Debettencourt, Matthew Douglas, Thomas Birkle, Christopher B. Ickler, Kenneth Dylan Jacob
  • Patent number: 7643640
    Abstract: The invention is directed to a display and method for conducting sound system design. The display is configured to simultaneously show a sound system model comprising both audio components and sound environment components, a plurality of parameters and a graphic representation of a calculated sound system performance attribute. In response to receiving input from the user and without any additional user intervention, the display re-displays a newly-calculated sound system performance attribute such as, for example, a graphic representation in the sound system model of a sound path associated with a user-selected reflected sound identifier. A processor also simulates, based on the sound system configuration, the sound performance that a user would expect to hear positioned in an identified listening position of the sound system model.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: January 5, 2010
    Assignee: Bose Corporation
    Inventors: Morten Jorgensen, Michael C. Monks, Lisa Debettencourt, Matthew Douglas, Thomas Birkle, Christopher B. Ickler, Kenneth Dylan Jacob
  • Patent number: 7319767
    Abstract: A line array electroacoustical transducing system includes at least first and second line arrays detachably secured in electrical and mechanical coupling relationships. The assembly may be detachably secured to a base having an amplifier in electrical and mechanical coupling relationships.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: January 15, 2008
    Assignee: Bose Corporation
    Inventors: Paul Fidlin, Clifford A. Henricksen, Kenneth Dylan Jacob, Hilmar Lehnert, Peter C. Santoro